| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3938572 | Fertility and Sterility | 2013 | 15 Pages |
Abstract
Mifepristone significantly reduced uterine and leiomyoma volume and alleviated leiomyoma-related symptoms. We recommend 2.5 mg of mifepristone administered daily for 3 or 6 months as the optimum clinical treatment for leiomyoma. There is insufficient evidence that mifepristone treatment led to atypical endometrial hyperplasia.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Qi M.D., Ying M.D., Ph.D., Wenxiao M.D., Wenwen M.D., Miaomiao M.D., Xueqiong M.D., Ph.D.,